
    
      Patients may be enrolled following their AUTO CAR T cell therapy treatment and will be
      followed for up to 15 years (or death, whichever happens first) after the first AUTO CAR T
      cell therapy infusion. Patients will be monitored for safety following the first AUTO CAR T
      cell therapy infusion.
    
  